1. Home
  2. CTKB vs AVNS Comparison

CTKB vs AVNS Comparison

Compare CTKB & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • AVNS
  • Stock Information
  • Founded
  • CTKB 1990
  • AVNS 2014
  • Country
  • CTKB United States
  • AVNS United States
  • Employees
  • CTKB N/A
  • AVNS N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AVNS Industrial Specialties
  • Sector
  • CTKB Health Care
  • AVNS Health Care
  • Exchange
  • CTKB Nasdaq
  • AVNS Nasdaq
  • Market Cap
  • CTKB 718.8M
  • AVNS 717.4M
  • IPO Year
  • CTKB 2021
  • AVNS N/A
  • Fundamental
  • Price
  • CTKB $5.12
  • AVNS $15.45
  • Analyst Decision
  • CTKB Strong Buy
  • AVNS Hold
  • Analyst Count
  • CTKB 2
  • AVNS 1
  • Target Price
  • CTKB $9.25
  • AVNS N/A
  • AVG Volume (30 Days)
  • CTKB 747.0K
  • AVNS 438.7K
  • Earning Date
  • CTKB 02-27-2025
  • AVNS 02-26-2025
  • Dividend Yield
  • CTKB N/A
  • AVNS N/A
  • EPS Growth
  • CTKB N/A
  • AVNS N/A
  • EPS
  • CTKB N/A
  • AVNS 0.34
  • Revenue
  • CTKB $201,210,000.00
  • AVNS $681,500,000.00
  • Revenue This Year
  • CTKB $7.26
  • AVNS $3.84
  • Revenue Next Year
  • CTKB $8.20
  • AVNS $4.37
  • P/E Ratio
  • CTKB N/A
  • AVNS $32.87
  • Revenue Growth
  • CTKB 9.88
  • AVNS N/A
  • 52 Week Low
  • CTKB $4.66
  • AVNS $14.98
  • 52 Week High
  • CTKB $9.33
  • AVNS $25.36
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 37.48
  • AVNS 36.25
  • Support Level
  • CTKB $5.18
  • AVNS $15.16
  • Resistance Level
  • CTKB $5.48
  • AVNS $16.75
  • Average True Range (ATR)
  • CTKB 0.27
  • AVNS 0.52
  • MACD
  • CTKB 0.01
  • AVNS -0.15
  • Stochastic Oscillator
  • CTKB 27.85
  • AVNS 11.97

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About AVNS Avanos Medical Inc.

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

Share on Social Networks: